Mr. James Durward reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) ANNOUNCES THE CLOSING OF THE MINDBALANCED INC. ACQUISITION AND THE APPOINTMENT OF JOSHUA HILL AS PRESIDENT

On April 16, 2024, Ndatalyze Corp.'s board of directors approved the previously announced (March 14, 2024) agreement to acquire 100 per cent of Mindbalanced Inc. in the state of Florida, United States. The terms and conditions of the transaction as set out in the previous release remain essentially the same, and the Canadian Securities Exchange has informed the corporation that the transaction, as structured, does not require CSE approval. Consistent with the terms and conditions of the transaction, Dr. Keith Courtney has resigned as the corporation's president and is replaced by Joshua Hill. Dr. Courtney will remain as the corporation's chief psychiatric officer. Mr. Hill will also become a member of the corporation's board of directors, and it is expected that Mr. Hill will nominate one other director in due course.

Jim Durward, chief executive officer, stated: "I'm extremely happy with this transaction. Not only is it low risk for Ndatalyze, but it offers significant near-term revenue potential, as well as a market penetration point for our advanced YMI analytical tool. As president, Josh Hill can now apply his experience in specialty pharmaceuticals and complex regulatory landscapes to drive the corporation forward. Once Josh has settled into his new position, I expect he will be announcing more details as to his plans for the future."

We seek Safe Harbor.